mupirocin

Generic: mupirocin

Labeler: padagis israel pharmaceuticals ltd
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name mupirocin
Generic Name mupirocin
Labeler padagis israel pharmaceuticals ltd
Dosage Form OINTMENT
Routes
TOPICAL
Active Ingredients

mupirocin 20 mg/g

Manufacturer
Padagis Israel Pharmaceuticals Ltd

Identifiers & Regulatory

Product NDC 45802-112
Product ID 45802-112_d51e7348-2495-41d4-93c1-bfaef2dac375
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA065123
Listing Expiration 2026-12-31
Marketing Start 2009-10-30

Pharmacologic Class

Established (EPC)
rna synthetase inhibitor antibacterial [epc]
Mechanism of Action
rna synthetase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 45802112
Hyphenated Format 45802-112

Supplemental Identifiers

RxCUI
106346
UNII
D0GX863OA5
NUI
N0000175515 N0000175516

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name mupirocin (source: ndc)
Generic Name mupirocin (source: ndc)
Application Number ANDA065123 (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/g
source: ndc
Packaging
  • 1 TUBE in 1 CARTON (45802-112-14) / 15 g in 1 TUBE
  • 1 TUBE in 1 CARTON (45802-112-22) / 22 g in 1 TUBE
source: ndc

Packages (2)

Ingredients (1)

mupirocin (20 mg/g)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "d51e7348-2495-41d4-93c1-bfaef2dac375", "openfda": {"nui": ["N0000175515", "N0000175516"], "unii": ["D0GX863OA5"], "rxcui": ["106346"], "spl_set_id": ["e9b61f01-3c67-42a4-a62b-10f1d1343190"], "pharm_class_epc": ["RNA Synthetase Inhibitor Antibacterial [EPC]"], "pharm_class_moa": ["RNA Synthetase Inhibitors [MoA]"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (45802-112-14)  / 15 g in 1 TUBE", "package_ndc": "45802-112-14", "marketing_start_date": "20221008"}, {"sample": false, "description": "1 TUBE in 1 CARTON (45802-112-22)  / 22 g in 1 TUBE", "package_ndc": "45802-112-22", "marketing_start_date": "20091030"}], "brand_name": "mupirocin", "product_id": "45802-112_d51e7348-2495-41d4-93c1-bfaef2dac375", "dosage_form": "OINTMENT", "pharm_class": ["RNA Synthetase Inhibitor Antibacterial [EPC]", "RNA Synthetase Inhibitors [MoA]"], "product_ndc": "45802-112", "generic_name": "Mupirocin", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "mupirocin", "active_ingredients": [{"name": "MUPIROCIN", "strength": "20 mg/g"}], "application_number": "ANDA065123", "marketing_category": "ANDA", "marketing_start_date": "20091030", "listing_expiration_date": "20261231"}